| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurexin family protein binding | 4.88e-07 | 16 | 210 | 5 | GO:0042043 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 9.19e-05 | 9 | 210 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB3 HIPK1 MAP3K5 PHKA2 CIITA FGFR4 TAF1 NME7 MAP4K3 CAMK2G ACVR1C STK31 HIPK3 EGFR MAP4K5 IRAK3 EPHB1 | 2.15e-04 | 600 | 210 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 3.03e-04 | 13 | 210 | 3 | GO:0008046 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 2.52e-08 | 10 | 210 | 5 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 4.59e-08 | 11 | 210 | 5 | GO:0097104 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.26e-07 | 13 | 210 | 5 | GO:0097090 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 4.16e-07 | 16 | 210 | 5 | GO:0007158 | |
| GeneOntologyBiologicalProcess | terminal button organization | 1.26e-06 | 9 | 210 | 4 | GO:0072553 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 8.08e-06 | 166 | 210 | 10 | GO:0098773 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF18A INTU MYO5A CATSPERD TTC21A FSIP2 CFAP54 KIF5B IFT80 SPAG16 NME7 AGTPBP1 APOB KLC4 ACTR2 CELSR2 VANGL1 | 1.29e-05 | 493 | 210 | 17 | GO:0007018 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 ABCA12 VSIG4 CDH23 EXT1 ITGA2B ADGRV1 GCNT1 NLGN3 NLGN4X MAD1L1 PKHD1 NLGN2 ZAN NLGN4Y ITGA10 ST3GAL4 NLGN1 PCDH20 CLDN1 CELSR2 EGFR LRP5 ROBO2 DSG4 HAS2 PCDHGA8 | 1.44e-05 | 1077 | 210 | 27 | GO:0098609 |
| GeneOntologyBiologicalProcess | respiratory system process | 1.98e-05 | 55 | 210 | 6 | GO:0003016 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 2.20e-05 | 56 | 210 | 6 | GO:0001941 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 3.28e-05 | 60 | 210 | 6 | GO:0099054 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, GABAergic | 4.45e-05 | 20 | 210 | 4 | GO:0032230 | |
| GeneOntologyBiologicalProcess | respiratory gaseous exchange by respiratory system | 4.63e-05 | 93 | 210 | 7 | GO:0007585 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 5.61e-05 | 8 | 210 | 3 | GO:1902474 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 5.61e-05 | 8 | 210 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 MYO5A HIPK1 EXT1 PLXND1 ADGRE2 NRN1 NLGN3 STRN NLGN4X PTPRJ PTPRK PKHD1 NLGN2 KIF5B PLEC NLGN4Y NLGN1 ACTR2 CLDN1 VPS35 LRP5 ROBO2 EPHB1 | 5.86e-05 | 974 | 210 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB3 HIPK1 PLXND1 ADGRE2 NLGN3 STRN NLGN4X PTPRJ PTPRK NLGN2 PLEC NLGN4Y NLGN1 CLDN1 VPS35 ROBO2 EPHB1 | 7.77e-05 | 569 | 210 | 17 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 7.80e-05 | 136 | 210 | 8 | GO:1901890 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF18A INTU STAG1 MYO5A CATSPERD TTC21A DDB1 FSIP2 TUBB6 CFAP54 PKHD1 KIF5B IFT80 TACC3 SPAG16 TRIM36 NME7 GOLGA2 AGTPBP1 APOB KLC4 ACTR2 PTPA CELSR2 VANGL1 | 7.97e-05 | 1058 | 210 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | vocalization behavior | 9.46e-05 | 24 | 210 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | presynapse organization | 1.00e-04 | 73 | 210 | 6 | GO:0099172 | |
| GeneOntologyBiologicalProcess | localization within membrane | MYO5A ABCA12 ZDHHC3 ADCY6 EHD4 PTPN9 PPIL2 NLGN2 KIF5B IFT80 NME7 CAMK2G ARFGEF2 NLGN1 EXOC8 NUP155 EGFR VPS35 LRP5 STOM | 1.99e-04 | 798 | 210 | 20 | GO:0051668 |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 2.14e-04 | 12 | 210 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB3 INTU NAGLU EXT1 VIT NLGN3 NLGN4X PTPRJ CLU IFT80 TAF1 TACC3 HERC1 NME7 AGTPBP1 NOVA2 NLGN4Y DHX37 ANXA3 ABCB6 CCDC141 CELSR2 EGFR LRP5 ROBO2 EPHB1 | 2.19e-04 | 1197 | 210 | 26 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 2.35e-04 | 202 | 210 | 9 | GO:0051963 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 2.48e-04 | 86 | 210 | 6 | GO:0051965 | |
| GeneOntologyBiologicalProcess | mucociliary clearance | 2.76e-04 | 13 | 210 | 3 | GO:0120197 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | INTU MYO5A TTC21A CFAP54 KIF5B IFT80 SPAG16 NME7 AGTPBP1 VANGL1 | 2.80e-04 | 253 | 210 | 10 | GO:0099111 |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 3.07e-04 | 3 | 210 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | organelle localization | KIF18A MYO5A NAGLU ADGRE2 NLGN3 MAD1L1 PKHD1 NLGN2 KIF5B TACC3 CLUH GOLGA2 AGTPBP1 NLGN1 ACTR2 EXOC8 ABCE1 CTBP2 | 3.24e-04 | 703 | 210 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB3 PLXND1 ADGRE2 NLGN3 NLGN4X NLGN2 NLGN4Y NLGN1 VPS35 ROBO2 EPHB1 | 3.34e-04 | 308 | 210 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | protein localization to membrane | MYO5A ABCA12 ZDHHC3 ADCY6 EHD4 PTPN9 PPIL2 NLGN2 KIF5B IFT80 NME7 CAMK2G NLGN1 NUP155 EGFR VPS35 LRP5 STOM | 3.35e-04 | 705 | 210 | 18 | GO:0072657 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | EPHB3 ADGRE2 NLGN3 NLGN4X PTPRJ NLGN2 NLGN1 CLDN1 VPS35 ROBO2 EPHB1 | 3.43e-04 | 309 | 210 | 11 | GO:1901888 |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange by nervous system process | 3.49e-04 | 14 | 210 | 3 | GO:0002087 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 3.77e-04 | 130 | 210 | 7 | GO:1905477 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 3.79e-04 | 93 | 210 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 4.49e-04 | 96 | 210 | 6 | GO:0048488 | |
| GeneOntologyBiologicalProcess | membrane assembly | 4.88e-04 | 64 | 210 | 5 | GO:0071709 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | MYO5A ABCA12 ZDHHC3 ADCY6 EHD4 PTPN9 PPIL2 KIF5B CAMK2G EGFR VPS35 | 5.11e-04 | 324 | 210 | 11 | GO:0072659 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 5.87e-04 | 278 | 210 | 10 | GO:0031503 | |
| GeneOntologyBiologicalProcess | developmental maturation | MYO5A CATSPERD EXT1 NRN1 IFT80 REC8 TUT4 NLGN1 STK31 VPS35 EBP ROBO2 DSG4 | 5.92e-04 | 439 | 210 | 13 | GO:0021700 |
| GeneOntologyBiologicalProcess | regulation of terminal button organization | 6.11e-04 | 4 | 210 | 2 | GO:2000331 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 6.11e-04 | 4 | 210 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 6.20e-04 | 102 | 210 | 6 | GO:0140238 | |
| GeneOntologyBiologicalProcess | regulation of respiratory system process | 6.37e-04 | 17 | 210 | 3 | GO:0044065 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | EPHB3 ADGRE2 NRN1 NLGN3 NLGN4X NLGN2 KIF5B NLGN1 ACTR2 VPS35 ROBO2 EPHB1 | 6.43e-04 | 387 | 210 | 12 | GO:0050807 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.07e-08 | 4 | 214 | 4 | GO:0098983 | |
| GeneOntologyCellularComponent | symmetric synapse | 1.29e-07 | 13 | 214 | 5 | GO:0032280 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.47e-05 | 31 | 214 | 5 | GO:0060077 | |
| GeneOntologyCellularComponent | stereocilium | 7.52e-05 | 69 | 214 | 6 | GO:0032420 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 9.66e-05 | 24 | 214 | 4 | GO:0098985 | |
| GeneOntologyCellularComponent | receptor complex | GABRQ PLXND1 ITGA2B ADGRV1 NRN1 PTPRQ FGFR4 ITGA10 NLGN1 ACVR1C PKD1L3 LEPR EGFR TAS1R2 LRP5 TRBC2 TRBC1 | 1.07e-04 | 581 | 214 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | stereocilium bundle | 1.60e-04 | 79 | 214 | 6 | GO:0032421 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.84e-04 | 153 | 214 | 8 | GO:0097731 | |
| GeneOntologyCellularComponent | cell surface | INTU TNFSF13 SIGLEC8 ITGA2B ADGRV1 ADGRE2 MAP3K5 NLGN3 NLGN4X PTPRJ PTPRK CIITA CLU PKHD1 NLGN2 NLGN4Y ITGA10 NLGN1 ACVR1C PKD1L3 LCT LEPR ANTXRL EGFR ROBO2 | 1.87e-04 | 1111 | 214 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | non-motile cilium | 1.96e-04 | 196 | 214 | 9 | GO:0097730 | |
| GeneOntologyCellularComponent | leading edge membrane | 3.26e-04 | 210 | 214 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | cilium | INTU MYO5A CATSPERD TTC21A CDH23 EVC ADGRV1 ADCY6 FSIP2 NXNL1 RAB28 CFAP54 PTPRK PKHD1 KIF5B IFT80 SPAG16 NME7 USH2A ARFGEF2 GUCA2B | 3.79e-04 | 898 | 214 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.05e-04 | 223 | 214 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | actin-based cell projection | MYO1G MYO5A CDH23 ADGRV1 ADCY6 PTPRQ USH2A NLGN1 PKHD1L1 EPHB1 | 6.13e-04 | 278 | 214 | 10 | GO:0098858 |
| GeneOntologyCellularComponent | USH2 complex | 6.17e-04 | 4 | 214 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | endocytic vesicle | EHD4 NLGN3 AP2A2 KIF5B RAB5C SFTPC CAMK2G ANXA3 APOB EGFR HCLS1 ATP6V0A2 | 6.31e-04 | 384 | 214 | 12 | GO:0030139 |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 6.47e-04 | 17 | 214 | 3 | GO:0090443 | |
| GeneOntologyCellularComponent | cell leading edge | MYO1G KIF18A MYO5A PLXND1 ADGRV1 ADGRE2 MEFV PTPRJ PTPRK USH2A ACTR2 EXOC8 EGFR ROBO2 | 6.74e-04 | 500 | 214 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | glycinergic synapse | 1.06e-03 | 20 | 214 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | filopodium tip | 1.06e-03 | 20 | 214 | 3 | GO:0032433 | |
| GeneOntologyCellularComponent | specific granule | 1.33e-03 | 160 | 214 | 7 | GO:0042581 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.52e-03 | 6 | 214 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.52e-03 | 6 | 214 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.52e-03 | 6 | 214 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.52e-03 | 6 | 214 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.53e-03 | 164 | 214 | 7 | GO:0098982 | |
| GeneOntologyCellularComponent | secretory granule | AOC1 MYO5A ABCA12 ITGA2B HRNR DDOST AP2A2 PTPRJ CLU TRIM36 RAB5C SFTPC ANXA3 UBR4 STK31 ACTR2 ORM1 ORM2 STOM ZG16 ATP6V0A2 | 1.76e-03 | 1014 | 214 | 21 | GO:0030141 |
| GeneOntologyCellularComponent | lysosome | MYO5A NAGLU HRNR DDOST DNASE2B AP2A2 KIF5B RAB5C DAGLB ABCB6 APOB ACTR2 ORM2 NPRL2 VPS35 HAS2 STOM ATP6V0A2 | 1.78e-03 | 811 | 214 | 18 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | MYO5A NAGLU HRNR DDOST DNASE2B AP2A2 KIF5B RAB5C DAGLB ABCB6 APOB ACTR2 ORM2 NPRL2 VPS35 HAS2 STOM ATP6V0A2 | 1.78e-03 | 811 | 214 | 18 | GO:0000323 |
| GeneOntologyCellularComponent | vacuole | MYO5A NAGLU HRNR MEFV DDOST DNASE2B AP2A2 KIF5B RAB5C DAGLB ABCB6 APOB ACTR2 ORM2 NPRL2 VPS35 HAS2 STOM ATP6V0A2 | 2.75e-03 | 913 | 214 | 19 | GO:0005773 |
| GeneOntologyCellularComponent | stereocilia coupling link | 2.80e-03 | 8 | 214 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 3.12e-03 | 139 | 214 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | Golgi membrane | PGAP3 ABCA12 COPB2 EXT1 GCNT1 ZDHHC3 GALNT13 GOLGA2 RHBDF1 ARFGEF2 ABCB6 ST3GAL4 RAB36 EGFR HAS2 ATP6V0A2 | 3.17e-03 | 721 | 214 | 16 | GO:0000139 |
| GeneOntologyCellularComponent | dendrite | EPHB3 MYO5A NLGN3 STRN NLGN4X PTPRK CLU STRN4 NLGN2 KIF5B PLEC NCOA2 STRN3 NLGN4Y ANXA3 ARFGEF2 NLGN1 EPHB1 | 3.25e-03 | 858 | 214 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB3 MYO5A NLGN3 STRN NLGN4X PTPRK CLU STRN4 NLGN2 KIF5B PLEC NCOA2 STRN3 NLGN4Y ANXA3 ARFGEF2 NLGN1 EPHB1 | 3.33e-03 | 860 | 214 | 18 | GO:0097447 |
| Domain | Nlgn | 1.67e-10 | 5 | 209 | 5 | IPR000460 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.09e-09 | 14 | 209 | 6 | PS00941 | |
| Domain | COesterase | 5.09e-09 | 14 | 209 | 6 | PF00135 | |
| Domain | CarbesteraseB | 5.09e-09 | 14 | 209 | 6 | IPR002018 | |
| Domain | Carboxylesterase_B_CS | 2.00e-07 | 13 | 209 | 5 | IPR019819 | |
| Domain | Striatin_N | 1.38e-06 | 3 | 209 | 3 | IPR013258 | |
| Domain | Striatin | 1.38e-06 | 3 | 209 | 3 | PF08232 | |
| Domain | WD40_repeat_dom | EML6 COPB2 NOL10 DDB1 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 UBR4 SEC31B | 6.78e-06 | 297 | 209 | 14 | IPR017986 |
| Domain | IPT | 1.10e-05 | 27 | 209 | 5 | SM00429 | |
| Domain | TIG | 2.24e-05 | 31 | 209 | 5 | PF01833 | |
| Domain | - | EML6 COPB2 NOL10 PLXND1 DDB1 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 2.45e-05 | 333 | 209 | 14 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | EML6 COPB2 NOL10 PLXND1 DDB1 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 2.61e-05 | 335 | 209 | 14 | IPR015943 |
| Domain | IPT | 2.63e-05 | 32 | 209 | 5 | IPR002909 | |
| Domain | WD40 | EML6 COPB2 NOL10 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 5.13e-05 | 268 | 209 | 12 | SM00320 |
| Domain | - | 5.83e-05 | 119 | 209 | 8 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 5.83e-05 | 119 | 209 | 8 | IPR029058 | |
| Domain | WD40_repeat | EML6 COPB2 NOL10 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 5.92e-05 | 272 | 209 | 12 | IPR001680 |
| Domain | WD_REPEATS_1 | EML6 COPB2 NOL10 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 7.30e-05 | 278 | 209 | 12 | PS00678 |
| Domain | WD_REPEATS_2 | EML6 COPB2 NOL10 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 7.55e-05 | 279 | 209 | 12 | PS50082 |
| Domain | WD_REPEATS_REGION | EML6 COPB2 NOL10 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 7.55e-05 | 279 | 209 | 12 | PS50294 |
| Domain | WD40_repeat_CS | 9.82e-05 | 164 | 209 | 9 | IPR019775 | |
| Domain | A1A_glycop | 1.25e-04 | 2 | 209 | 2 | IPR001500 | |
| Domain | NLGN4 | 1.25e-04 | 2 | 209 | 2 | IPR030025 | |
| Domain | Ig-like_fold | EPHB3 SIGLEC8 VSIG4 PLXND1 PTPRJ PTPRK PKHD1 FGFR4 TRIM36 USH2A EBF4 EBF3 CCDC141 PKHD1L1 LEPR ANTXRL ROBO2 TRBC1 MYBPC1 EPHB1 | 1.36e-04 | 706 | 209 | 20 | IPR013783 |
| Domain | WD40 | EML6 COPB2 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 1.68e-04 | 259 | 209 | 11 | PF00400 |
| Domain | - | EPHB3 SIGLEC8 VSIG4 PLXND1 PTPRJ PTPRK PKHD1 FGFR4 TRIM36 USH2A EBF4 EBF3 CCDC141 PKHD1L1 LEPR ANTXRL ROBO2 MYBPC1 EPHB1 | 1.74e-04 | 663 | 209 | 19 | 2.60.40.10 |
| Domain | FN3 | 2.44e-04 | 185 | 209 | 9 | SM00060 | |
| Domain | CPSF_A | 3.71e-04 | 3 | 209 | 2 | PF03178 | |
| Domain | Cleavage/polyA-sp_fac_asu_C | 3.71e-04 | 3 | 209 | 2 | IPR004871 | |
| Domain | G-protein_beta_WD-40_rep | 3.83e-04 | 85 | 209 | 6 | IPR020472 | |
| Domain | FN3 | 4.17e-04 | 199 | 209 | 9 | PS50853 | |
| Domain | fn3 | 4.87e-04 | 162 | 209 | 8 | PF00041 | |
| Domain | GPS | 5.43e-04 | 34 | 209 | 4 | SM00303 | |
| Domain | BACK | 5.54e-04 | 60 | 209 | 5 | SM00875 | |
| Domain | CNH | 5.69e-04 | 15 | 209 | 3 | PF00780 | |
| Domain | CNH | 5.69e-04 | 15 | 209 | 3 | PS50219 | |
| Domain | CNH_dom | 5.69e-04 | 15 | 209 | 3 | IPR001180 | |
| Domain | FN3_dom | 5.94e-04 | 209 | 209 | 9 | IPR003961 | |
| Domain | BACK | 5.98e-04 | 61 | 209 | 5 | IPR011705 | |
| Domain | BACK | 5.98e-04 | 61 | 209 | 5 | PF07707 | |
| Domain | GPS | 6.08e-04 | 35 | 209 | 4 | PF01825 | |
| Domain | PTPc | 6.78e-04 | 36 | 209 | 4 | SM00194 | |
| Domain | GPS | 6.78e-04 | 36 | 209 | 4 | PS50221 | |
| Domain | G8_domain | 7.37e-04 | 4 | 209 | 2 | IPR019316 | |
| Domain | G8 | 7.37e-04 | 4 | 209 | 2 | PS51484 | |
| Domain | COE | 7.37e-04 | 4 | 209 | 2 | PS01345 | |
| Domain | G8 | 7.37e-04 | 4 | 209 | 2 | SM01225 | |
| Domain | Transcription_factor_COE | 7.37e-04 | 4 | 209 | 2 | IPR003523 | |
| Domain | MAPKKKK | 7.37e-04 | 4 | 209 | 2 | IPR021160 | |
| Domain | G8 | 7.37e-04 | 4 | 209 | 2 | PF10162 | |
| Domain | COE_HLH | 7.37e-04 | 4 | 209 | 2 | IPR032201 | |
| Domain | COE_DBD | 7.37e-04 | 4 | 209 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 7.37e-04 | 4 | 209 | 2 | IPR018350 | |
| Domain | COE1_HLH | 7.37e-04 | 4 | 209 | 2 | PF16423 | |
| Domain | COE1_DBD | 7.37e-04 | 4 | 209 | 2 | PF16422 | |
| Domain | GPS | 7.53e-04 | 37 | 209 | 4 | IPR000203 | |
| Domain | ConA-like_dom | 8.29e-04 | 219 | 209 | 9 | IPR013320 | |
| Domain | TYR_PHOSPHATASE_PTP | 9.22e-04 | 39 | 209 | 4 | PS50055 | |
| Domain | PTPase_domain | 1.12e-03 | 41 | 209 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.12e-03 | 41 | 209 | 4 | PF00102 | |
| Domain | Ig_E-set | 1.12e-03 | 104 | 209 | 6 | IPR014756 | |
| Domain | BTB-kelch_protein | 1.34e-03 | 43 | 209 | 4 | IPR017096 | |
| Domain | Tyr_Pase_AS | 1.36e-03 | 73 | 209 | 5 | IPR016130 | |
| Domain | PbH1 | 1.81e-03 | 6 | 209 | 2 | SM00710 | |
| Domain | PbH1 | 1.81e-03 | 6 | 209 | 2 | IPR006626 | |
| Domain | PROTEIN_KINASE_ATP | EPHB3 HIPK1 MAP3K5 FGFR4 MAP4K3 CAMK2G ACVR1C STK31 HIPK3 EGFR MAP4K5 IRAK3 EPHB1 | 2.06e-03 | 459 | 209 | 13 | PS00107 |
| Domain | VWFA | 2.27e-03 | 82 | 209 | 5 | PS50234 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 2.62e-05 | 32 | 158 | 5 | MM15326 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 3.06e-05 | 33 | 158 | 5 | M39875 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 4.11e-05 | 18 | 158 | 4 | M48098 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | KIF18A UGGT1 NAGLU EXT1 PLXND1 GCNT1 ADGRE2 DDB1 DDOST USP19 PTPRJ PTPRK CLU CPSF1 KIF5B FGFR4 GOLGA2 RAB5C SLC27A3 MGRN1 SEL1L DGCR2 ARFGEF2 ST3GAL4 CELSR2 EGFR ABCE1 VPS35 EBP LRP5 STOM ATP6V0A2 | 3.78e-12 | 1201 | 215 | 32 | 35696571 |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 8.62e-12 | 5 | 215 | 5 | 10996085 | |
| Pubmed | 8.62e-12 | 5 | 215 | 5 | 37865312 | ||
| Pubmed | 5.14e-11 | 6 | 215 | 5 | 21838267 | ||
| Pubmed | 5.14e-11 | 6 | 215 | 5 | 29724786 | ||
| Pubmed | MYO5A DDB1 MAP3K5 TUBB6 NLGN3 STRN PTPN9 AP2A2 CLU FAM120C PI4KA MAD1L1 STRN4 NLGN2 KIF5B TACC3 GOLGA2 NCOA2 SESTD1 STRN3 EBF3 CAMK2G UBR4 CELSR2 CTBP2 NEURL4 | 3.58e-10 | 963 | 215 | 26 | 28671696 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 4.75e-10 | 8 | 215 | 5 | 30871858 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 INTU MYO5A TTC21A EVC CTIF ADGRV1 NLGN3 PTPN4 RAB28 SLC41A3 PTPRJ SH3TC1 FAM120C TGFBRAP1 MAD1L1 KLHL23 NLGN2 GPT2 MGRN1 NCOA2 PSAT1 TUT4 NLGN4Y ATP10A HIPK3 EGFR LRP5 SLC35F2 CTBP2 UBE3C CPNE7 | 8.72e-10 | 1489 | 215 | 32 | 28611215 |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.42e-09 | 4 | 215 | 4 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.42e-09 | 4 | 215 | 4 | 22671294 | |
| Pubmed | 1.42e-09 | 4 | 215 | 4 | 16077734 | ||
| Pubmed | 3.86e-09 | 11 | 215 | 5 | 26403076 | ||
| Pubmed | 3.86e-09 | 11 | 215 | 5 | 32973045 | ||
| Pubmed | KIF18A STAG1 HIPK1 ZDHHC3 DDB1 PHKA2 STRN AP2A2 PLEC HERC1 DGCR2 UBR4 ARFGEF2 HIPK3 NUP155 VPS35 LRP5 CTBP2 SMAD6 | 6.12e-09 | 591 | 215 | 19 | 15231748 | |
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 7.07e-09 | 5 | 215 | 4 | 15620359 | |
| Pubmed | UGGT1 HRNR DDB1 TUBB6 STRN PI4KA GPT2 STRN3 PSAT1 CAMK2G UBR4 KLC4 NUP155 EGFR | 7.86e-09 | 304 | 215 | 14 | 32235678 | |
| Pubmed | KIF18A RNGTT MYO5A UGGT1 COPB2 NAGLU NOL10 DDOST EHD4 TUBB6 PTPN4 PTPN9 PTPRJ PTPRK PI4KA CPSF1 HERC1 TRIM36 AGTPBP1 PSAT1 PTPA NUP155 EGFR VANGL1 NEURL4 | 9.74e-09 | 1049 | 215 | 25 | 27880917 | |
| Pubmed | 2.46e-08 | 15 | 215 | 5 | 18227507 | ||
| Pubmed | 3.56e-08 | 16 | 215 | 5 | 17567809 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ACADM TTC21A UGGT1 COPB2 NAGLU EXT1 CTIF SQOR DDB1 DDOST FBLN2 PTPRK FAM120C CPSF1 PLEC GPT2 RAB5C SLC27A3 SEL1L DGCR2 ACTR2 NUP155 CELSR2 EGFR NT5DC2 VPS35 EBP STOM | 1.05e-07 | 1451 | 215 | 28 | 30550785 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ACADM UGGT1 COPB2 DDB1 USP19 EHD4 TUBB6 CLU MAD1L1 STRN4 KIF5B PLEC HERC1 CLUH STRN3 PSAT1 UBR4 ARFGEF2 UBA3 KLC4 ACTR2 IVNS1ABP NUP155 ABCE1 VPS35 RPUSD2 CTBP2 UBE3C | 1.11e-07 | 1455 | 215 | 28 | 22863883 |
| Pubmed | 1.75e-07 | 9 | 215 | 4 | 9278515 | ||
| Pubmed | Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits. | 2.33e-07 | 3 | 215 | 3 | 29100073 | |
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 26291161 | ||
| Pubmed | Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. | 2.33e-07 | 3 | 215 | 3 | 17897391 | |
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 28607166 | ||
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 16982420 | ||
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 32011705 | ||
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 27217145 | ||
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 18628683 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 2.33e-07 | 3 | 215 | 3 | 21282647 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UGGT1 COPB2 NOL10 DDB1 DDOST USP19 DHX8 EHD4 AP2A2 PI4KA KLHL23 CPSF1 KIF5B CLUH PSAT1 DHX37 UBR4 APOB ACTR2 IVNS1ABP NUP155 ABCE1 NT5DC2 VPS35 CTBP2 UBE3C MYBPC1 | 2.59e-07 | 1425 | 215 | 27 | 30948266 |
| Pubmed | UGGT1 COPB2 NAGLU ITGA2B HRNR DDOST TUBB6 PTPRJ CLU MGRN1 SEL1L LEPR IVNS1ABP NUP155 EGFR ABCE1 STOM | 3.22e-07 | 613 | 215 | 17 | 22268729 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 5.10e-07 | 26 | 215 | 5 | 34848499 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RNGTT UGGT1 COPB2 DDB1 DDOST PTPN4 PTPN9 PTPRK CLUH RAB5C SLC27A3 SEL1L ANXA3 UBR4 EXOC8 NUP155 ABCE1 VANGL1 NT5DC2 VPS35 UBE3C | 8.10e-07 | 974 | 215 | 21 | 28675297 |
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 10748158 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 30056576 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 32719346 | ||
| Pubmed | Adenylyl cyclase 6 plays a minor role in the mouse inner ear and retina. | 9.28e-07 | 4 | 215 | 3 | 37127773 | |
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 20579107 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 27207522 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 17292328 | ||
| Pubmed | Retrograde regulation of mossy fiber axon targeting and terminal maturation via postsynaptic Lnx1. | 9.72e-07 | 13 | 215 | 4 | 30185604 | |
| Pubmed | 1.08e-06 | 30 | 215 | 5 | 12676797 | ||
| Pubmed | INTU STAG1 MYO5A UGGT1 EML6 ADCY6 EHD4 STRN AP2A2 STRN4 PKHD1 KIF5B PLEC STRN3 CAMK2G UBR4 APOB STK31 ACTR2 ZC3H7A VPS35 CES3 IRAK3 PCDHGA8 HCLS1 MYBPC1 | 1.11e-06 | 1442 | 215 | 26 | 35575683 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | UGGT1 COPB2 EXT1 HRNR DDOST CNOT8 EHD4 STRN STRN4 KIF5B HERC1 RAB5C STRN3 EBF3 DHX37 UBR4 UBA3 KLC4 PKD1L3 ACTR2 NPRL2 VPS35 NEURL4 STOM | 1.60e-06 | 1284 | 215 | 24 | 17353931 |
| Pubmed | MYO5A UGGT1 DDB1 DDOST EHD4 TUBB6 PLEKHG1 CLU PI4KA IFT80 NME7 FAM135A CLUH AGTPBP1 DGCR2 UBR4 ZC3H7A NUP155 EGFR VANGL1 MAP4K5 NT5DC2 VPS35 NEURL4 STOM ATP6V0A2 | 1.95e-06 | 1487 | 215 | 26 | 33957083 | |
| Pubmed | UGGT1 ZDHHC3 ADCY6 DDOST EHD4 TUBB6 GOLGA2 RAB5C MGRN1 DGCR2 ARFGEF2 ACTR2 NUP155 ABCE1 VANGL1 NT5DC2 EBP SLC35F2 CTBP2 STOM | 2.22e-06 | 952 | 215 | 20 | 38569033 | |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 28939043 | ||
| Pubmed | 5-HT modulation of a medial septal circuit tunes social memory stability. | 2.31e-06 | 5 | 215 | 3 | 34616037 | |
| Pubmed | Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons. | 2.31e-06 | 5 | 215 | 3 | 27581450 | |
| Pubmed | 2.31e-06 | 5 | 215 | 3 | 18502210 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF18A INTU RNGTT TTC21A CDH23 ADCY6 STRN RAB28 AP2A2 PTPRQ IFT80 PLEC SPAG16 NME7 CLUH SESTD1 EBF3 KLC4 EXOC8 IVNS1ABP EBP CTBP2 NEURL4 STOM | 2.60e-06 | 1321 | 215 | 24 | 27173435 |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | KBTBD7 MAP3K5 KLHL23 TRIM36 NR1I3 CAMK2G ACVR1C NPRL2 KBTBD4 EGFR IRAK3 EPHB1 | 4.01e-06 | 372 | 215 | 12 | 22939624 |
| Pubmed | AOC1 UGGT1 COPB2 ADGRE2 CNOT8 NLGN3 ALKBH8 UBP1 PI4KA PLEC HERC1 FAM135A NCOA2 SESTD1 RHBDF1 MAP4K3 APOB GPR183 ABCE1 SLC35F2 ATP6V0A2 | 4.32e-06 | 1084 | 215 | 21 | 11544199 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MYO5A COPB2 SQOR PI4KA CPSF1 CAMK2G UBR4 UBE3C NEURL4 STOM ATP6V0A2 | 4.54e-06 | 313 | 215 | 11 | 38270169 |
| Pubmed | Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis. | 4.60e-06 | 6 | 215 | 3 | 36050503 | |
| Pubmed | 4.60e-06 | 6 | 215 | 3 | 29742426 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 4.60e-06 | 6 | 215 | 3 | 8576240 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ACADM DDOST USP19 DHX8 STRN KLHL23 STRN4 KIF5B PLEC GPT2 STRN3 CAMK2G UBA3 EXOC8 IVNS1ABP NUP155 ABCE1 VPS35 NEURL4 CPNE7 | 4.98e-06 | 1005 | 215 | 20 | 19615732 |
| Pubmed | 5.09e-06 | 257 | 215 | 10 | 30945288 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PGAP3 NAGLU PLXND1 MAP3K5 PLEKHG1 SH3TC1 PI4KA MAD1L1 STRN4 CPSF1 NLGN2 WDR90 PLEC HERC1 DGCR2 RHBDF1 UBR4 ARFGEF2 CELSR2 LRP5 UBE3C | 5.79e-06 | 1105 | 215 | 21 | 35748872 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SLC26A4 NAGLU ADGRV1 DDB1 EHD4 TUBB6 PTPRJ CLU PKHD1 RAB5C MGRN1 PSAT1 TUT4 ANXA3 ABCB6 PKD1L3 ACTR2 VPS35 ROBO2 STOM | 5.84e-06 | 1016 | 215 | 20 | 19056867 |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | UGGT1 DDOST TUBB6 AP2A2 NR1I3 RAB5C DAGLB SEL1L ABCB6 ACTR2 STOM ATP6V0A2 | 6.81e-06 | 392 | 215 | 12 | 33144569 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ACADM NOL10 DDB1 KBTBD7 DDOST USP19 EHD4 STRN PI4KA STRN4 CPSF1 HERC1 CLUH RAB5C STRN3 TUT4 UBR4 ACTR2 NUP155 ABCE1 VANGL1 NT5DC2 UBE3C NEURL4 STOM | 6.83e-06 | 1496 | 215 | 25 | 32877691 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | STAG1 HIPK1 COPB2 HRNR KBTBD7 PHKA2 SH3TC1 UBP1 PI4KA MAD1L1 KIF5B AGTPBP1 NOVA2 NCOA2 EBF3 UBR4 CTBP2 STOM | 7.31e-06 | 857 | 215 | 18 | 25609649 |
| Pubmed | RNGTT PLXND1 HRNR USP19 DNASE2B PI4KA TACC3 FAM135A ARFGEF2 APOB KBTBD2 PKHD1L1 NUP155 EGFR VANGL1 STOM ATP6V0A2 | 7.81e-06 | 777 | 215 | 17 | 35844135 | |
| Pubmed | 7.83e-06 | 21 | 215 | 4 | 37422473 | ||
| Pubmed | Identification of cellular proteins required for replication of human immunodeficiency virus type 1. | 7.83e-06 | 21 | 215 | 4 | 22404213 | |
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 20058854 | ||
| Pubmed | MYO5A DDB1 DDOST TUBB6 STRN STRN4 KIF5B CLUH STRN3 UBR4 NUP155 VANGL1 | 8.14e-06 | 399 | 215 | 12 | 37536630 | |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 1.07e-05 | 47 | 215 | 5 | 19167335 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 1.07e-05 | 47 | 215 | 5 | 14760718 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB3 PEX10 EXT1 PLXND1 ZDHHC3 ADCY6 PTPRJ CLU HERC1 MGRN1 DAGLB PSAT1 ARFGEF2 APOB CLDN1 PTPA CELSR2 EBP UBE3C ATP6V0A2 | 1.10e-05 | 1061 | 215 | 20 | 33845483 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | MYO5A NLGN3 STRN NLGN4X AP2A2 PI4KA SESTD1 NLGN4Y CAMK2G NLGN1 | 1.11e-05 | 281 | 215 | 10 | 28706196 |
| Pubmed | ACADM UGGT1 DDB1 DHX8 TUBB6 PTPN9 AP2A2 STRN4 CLUH SEL1L EXOC8 NUP155 NT5DC2 VPS35 | 1.17e-05 | 560 | 215 | 14 | 35241646 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A COPB2 NOL10 DDB1 DDOST EHD4 TUBB6 AP2A2 PI4KA CPSF1 KIF5B PLEC NME7 MAP4K3 DHX37 CAMK2G UBR4 ZC3H7A NUP155 ABCE1 MAP4K5 VPS35 CTBP2 | 1.25e-05 | 1353 | 215 | 23 | 29467282 |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 1.28e-05 | 8 | 215 | 3 | 19683999 | |
| Pubmed | Control of excitatory and inhibitory synapse formation by neuroligins. | 1.28e-05 | 8 | 215 | 3 | 15681343 | |
| Pubmed | 1.35e-05 | 125 | 215 | 7 | 29467281 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ADCY6 NLGN4X PTPRJ PI4KA FAM135A RHBDF1 ARFGEF2 APOB CLDN1 CELSR2 EGFR VANGL1 SLC35F2 STOM | 1.40e-05 | 569 | 215 | 14 | 30639242 |
| Pubmed | HIPK1 PLXND1 GALNT13 DNASE2B STRN AP2A2 PPIL2 TAF1 STRN3 TUT4 MAP4K3 CAMK2G HIPK3 EGFR CES3 ATP6V0A2 | 1.42e-05 | 730 | 215 | 16 | 34857952 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.50e-05 | 231 | 215 | 9 | 36597993 | |
| Pubmed | MYO5A UGGT1 COPB2 NOL10 DDB1 DHX8 CPSF1 KIF5B PLEC CLUH DHX37 UBR4 ACTR2 NUP155 ABCE1 | 1.54e-05 | 653 | 215 | 15 | 22586326 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.72e-05 | 235 | 215 | 9 | 30258100 | |
| Pubmed | 1.90e-05 | 9 | 215 | 3 | 23010509 | ||
| Pubmed | 1.90e-05 | 9 | 215 | 3 | 34919427 | ||
| Pubmed | Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition. | 1.91e-05 | 182 | 215 | 8 | 36225252 | |
| Pubmed | CPAMD8 RNGTT SIGLEC8 UGGT1 VSIG4 GCNT1 DDOST EHD4 TUBB6 NLGN3 CLU KIF5B TAF1 PLEC WDR17 RAB5C SEL1L ST3GAL4 IRAK3 HCLS1 STOM MYBPC1 | 1.92e-05 | 1293 | 215 | 22 | 15342556 | |
| Pubmed | RNGTT MYO5A NOL10 SQOR CNOT8 DHX8 TUBB6 STRN FAM120C UBP1 PI4KA STRN4 NR1I3 RAB5C SEL1L STRN3 RHBDF1 ABCB6 ZC3H7A VANGL1 CTBP2 LSM14B STOM ATP6V0A2 | 2.07e-05 | 1497 | 215 | 24 | 31527615 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ACADM MYO5A UGGT1 NAGLU NOL10 DDB1 AP2A2 GOLGA2 RAB5C SEL1L STRN3 DHX37 ZC3H7A UBE3C NEURL4 STOM | 2.11e-05 | 754 | 215 | 16 | 33060197 |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | UGGT1 COPB2 DDOST EHD4 PTPN9 FGFR4 RAB5C SLC27A3 SEL1L NUP155 VPS35 STOM ATP6V0A2 | 2.23e-05 | 516 | 215 | 13 | 36610398 |
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 2.33e-05 | 55 | 215 | 5 | 32561725 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 2.38e-05 | 307 | 215 | 10 | 37499664 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 2.71e-05 | 10 | 215 | 3 | 24618850 | |
| Pubmed | A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. | 2.71e-05 | 10 | 215 | 3 | 7690989 | |
| Pubmed | 2.71e-05 | 10 | 215 | 3 | 24239741 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ACADM COPB2 DDOST AP2A2 CPSF1 KIF5B CLUH RAB5C NUP155 ABCE1 NT5DC2 VPS35 CTBP2 STOM | 2.85e-05 | 607 | 215 | 14 | 39147351 |
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 3.29e-05 | 59 | 215 | 5 | 17330941 | |
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 3.43e-05 | 30 | 215 | 4 | 16186258 | |
| Interaction | LGALS1 interactions | ACADM NAGLU PLXND1 NLGN3 PTPRJ PTPRK CLUH RAB5C MGRN1 CELSR2 EGFR VANGL1 LSM14B STOM ATP6V0A2 | 2.53e-06 | 332 | 212 | 15 | int:LGALS1 |
| Interaction | TNIK interactions | MYO5A KBTBD7 GALNT13 STRN AP2A2 CLU STRN4 NLGN2 KIF5B FGFR4 AGTPBP1 STRN3 CAMK2G EGFR CTBP2 NEURL4 | 3.00e-06 | 381 | 212 | 16 | int:TNIK |
| Interaction | GPIHBP1 interactions | 1.17e-05 | 133 | 212 | 9 | int:GPIHBP1 | |
| GeneFamily | Fibronectin type III domain containing | 5.45e-06 | 160 | 144 | 9 | 555 | |
| GeneFamily | WD repeat domain containing | EML6 COPB2 STRN STRN4 WDR90 IFT80 HERC1 SPAG16 WDR17 STRN3 SEC31B | 8.20e-06 | 262 | 144 | 11 | 362 |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.10e-04 | 15 | 144 | 3 | 696 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 3.74e-04 | 4 | 144 | 2 | 1244 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 5.11e-04 | 20 | 144 | 3 | 1371 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.92e-04 | 21 | 144 | 3 | 813 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 6.20e-04 | 5 | 144 | 2 | 655 | |
| GeneFamily | Cohesin complex | 1.71e-03 | 8 | 144 | 2 | 1060 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | KIF18A RNGTT STAG1 STRN KIF5B IFT80 PLEC TRIM36 NME7 GPT2 WDR17 SEL1L PSAT1 ARFGEF2 ACTR2 CLDN1 EGFR MAP4K5 VPS35 UBE3C | 2.31e-06 | 721 | 215 | 20 | M10237 |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP | MYO5A TNFSF13 ADGRV1 ADGRE2 SQOR KIF5B AGTPBP1 ANXA3 KBTBD2 HAS2 | 6.48e-06 | 200 | 215 | 10 | M5528 |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-08 | 192 | 215 | 10 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5A VSIG4 PLXND1 AP2A2 CIITA GPR183 PKD1L3 CCDC141 IRAK3 HCLS1 | 3.85e-08 | 194 | 215 | 10 | c95d5c4ad0210ebd672926558cc8331e6396a854 |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.04e-08 | 195 | 215 | 10 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-07 | 184 | 215 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-07 | 184 | 215 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-07 | 184 | 215 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-07 | 185 | 215 | 9 | 0ab1be455f2cd883c9d1522ca78112c37833352e | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.19e-07 | 186 | 215 | 9 | b80aaeebc03a318052076d2f02c123f5ddc5e73a | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.19e-07 | 186 | 215 | 9 | 8a8ed1502542d4895cba3fd5d534256206578716 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.34e-07 | 187 | 215 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.99e-07 | 191 | 215 | 9 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 4.55e-07 | 194 | 215 | 9 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.55e-07 | 194 | 215 | 9 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 4.75e-07 | 195 | 215 | 9 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.96e-07 | 196 | 215 | 9 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-07 | 200 | 215 | 9 | 2554b77edfe3d378296b0b25625caacbfb1c0e76 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.87e-07 | 200 | 215 | 9 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-07 | 200 | 215 | 9 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.87e-07 | 200 | 215 | 9 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 160 | 215 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 160 | 215 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Myeloid-Myeloid-C_(Cd16+_Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 1.64e-06 | 117 | 215 | 7 | d1936e76a935216783a73ab414e4147fa48e68eb | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-06 | 169 | 215 | 8 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.33e-06 | 176 | 215 | 8 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-06 | 176 | 215 | 8 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 2.43e-06 | 177 | 215 | 8 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-06 | 178 | 215 | 8 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-06 | 181 | 215 | 8 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-06 | 182 | 215 | 8 | 09d0793245d3d77ab5fc384c0b62637f736da50b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-06 | 183 | 215 | 8 | d4a558bc0b8e11be195a7da1468ab38eb477117d | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 186 | 215 | 8 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.80e-06 | 188 | 215 | 8 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.96e-06 | 189 | 215 | 8 | 033a2be8bbb7bfb437e6f1657b6ca02070c74aa8 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-06 | 191 | 215 | 8 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.28e-06 | 191 | 215 | 8 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-06 | 191 | 215 | 8 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 4.44e-06 | 192 | 215 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-06 | 193 | 215 | 8 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 4.62e-06 | 193 | 215 | 8 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-06 | 193 | 215 | 8 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.62e-06 | 193 | 215 | 8 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-06 | 195 | 215 | 8 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 4.98e-06 | 195 | 215 | 8 | 56f88ce95495260360bf08f9c76cc36e395dc6a9 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.17e-06 | 196 | 215 | 8 | 5bb8653af62334ded8aad48b24b64d7b54bc3cd5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-06 | 196 | 215 | 8 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-06 | 196 | 215 | 8 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 197 | 215 | 8 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-06 | 197 | 215 | 8 | a78111171819db746af7b162c77f9a324453f3ce | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.57e-06 | 198 | 215 | 8 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-06 | 199 | 215 | 8 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 199 | 215 | 8 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-06 | 199 | 215 | 8 | ffebd99d55d31cf51b4878b2690ed0b9b3799223 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.78e-06 | 199 | 215 | 8 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.78e-06 | 199 | 215 | 8 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.78e-06 | 199 | 215 | 8 | d017dd91f9b10038f1f83753a766e534da2dbe89 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.78e-06 | 199 | 215 | 8 | 079931e7196719f22a89cfad82f452ec67219ee5 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.00e-06 | 200 | 215 | 8 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.00e-06 | 200 | 215 | 8 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.00e-06 | 200 | 215 | 8 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.00e-06 | 200 | 215 | 8 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.82e-06 | 145 | 215 | 7 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 145 | 215 | 7 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.28e-06 | 152 | 215 | 7 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 166 | 215 | 7 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 167 | 215 | 7 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 169 | 215 | 7 | b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 169 | 215 | 7 | 83d1bcf33872b01ea9614f608a3e4ab30df25c7e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 169 | 215 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 170 | 215 | 7 | 4fb4ce46e4fa2418238e264875209d7ebe844d82 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-05 | 171 | 215 | 7 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 172 | 215 | 7 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | FLU-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 2.15e-05 | 173 | 215 | 7 | 26e89ac86922f1cd0100cf4d1cce37e74dd31c88 | |
| ToppCell | FLU-Healthy-3|FLU / Virus stimulation, Condition and Cluster | 2.15e-05 | 173 | 215 | 7 | 32b8e5b400885dbeba57a7cb2c18d882664dc285 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.23e-05 | 174 | 215 | 7 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 2.23e-05 | 174 | 215 | 7 | 1e289b26e2c29dbad15b712a999b96c391a26129 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 175 | 215 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-05 | 177 | 215 | 7 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 178 | 215 | 7 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class （2021.01.30） | 2.58e-05 | 178 | 215 | 7 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.58e-05 | 178 | 215 | 7 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 179 | 215 | 7 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-05 | 179 | 215 | 7 | abc6797bd3884aa75dca58fcb2523ee321243ab1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-05 | 179 | 215 | 7 | 0b996d6e881f31e6b80d359f7caac70ecdeb9982 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.67e-05 | 179 | 215 | 7 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 180 | 215 | 7 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-05 | 183 | 215 | 7 | c7fedb5b0c1f17b3391ce1c4a6bfca7615c359c5 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-05 | 183 | 215 | 7 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 183 | 215 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 3.19e-05 | 184 | 215 | 7 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 215 | 7 | 53854a9ec87c24c360541c83d86d8fafb303ad58 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 215 | 7 | a61fc7a3700a1efcf640bef7680c0443ee148a46 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 3.30e-05 | 185 | 215 | 7 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 3.30e-05 | 185 | 215 | 7 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 186 | 215 | 7 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.41e-05 | 186 | 215 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 3.53e-05 | 187 | 215 | 7 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 187 | 215 | 7 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 187 | 215 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 187 | 215 | 7 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.53e-05 | 187 | 215 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | EPHB3 PGAP3 PLXND1 USP19 MAP3K5 STRN CLU PPIL2 ST3GAL4 CLDN1 HIPK3 STOM CPNE7 | 5.20e-08 | 198 | 214 | 13 | 5064_DN |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; HL60; HT_HG-U133A | PGAP3 SIGLEC8 EXT1 STRN FAM120C REC8 UBR4 ITGA10 E2F2 ST3GAL4 ORM2 LSM14B | 4.30e-07 | 199 | 214 | 12 | 6153_UP |
| Drug | p-hydroxyketorolac | 8.19e-07 | 3 | 214 | 3 | CID003082630 | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | SIGLEC8 PLXND1 NRN1 CNOT8 PPIL2 STRN3 CAMK2G ARFGEF2 ORM2 KBTBD4 LSM14B | 2.78e-06 | 197 | 214 | 11 | 1182_UP |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 1.39e-05 | 191 | 214 | 10 | 4442_UP | |
| Drug | mono-(2-ethylhexyl)phthalate | ACAP1 ABCA12 NUP210L CDH23 NRN1 GALNT13 TUBB6 FBLN2 AFM PKHD1 TAF1 WDR17 SEC14L4 NR1I3 ZAN EBF3 CELSR2 EBP HAS2 | 1.59e-05 | 658 | 214 | 19 | ctd:C016599 |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | RNGTT PEX10 CTIF MAP3K5 AP2A2 PPIL2 FGFR4 RAB5C DGCR2 ST3GAL4 | 1.67e-05 | 195 | 214 | 10 | 7435_UP |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | RNGTT USP19 MAP3K5 PPIL2 TAF1 NCOA2 DGCR2 STRN3 ITGA10 CLDN1 | 1.82e-05 | 197 | 214 | 10 | 3797_DN |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; HL60; HT_HG-U133A | RNGTT SIGLEC8 EXT1 FAM120C PPIL2 FAM135A STRN3 TUT4 CLDN1 LSM14B | 1.90e-05 | 198 | 214 | 10 | 3022_UP |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | RNGTT NAGLU ADCY6 RAB28 SH3TC1 FAM120C PPIL2 FGFR4 CES3 CPNE7 | 1.90e-05 | 198 | 214 | 10 | 3711_DN |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | ADGRE2 ADCY6 USP19 PPIL2 CLUH RAB5C REC8 DGCR2 SEC31B ATP10A | 1.99e-05 | 199 | 214 | 10 | 1729_UP |
| Disease | cortical thickness | CPAMD8 INTU NUP210L EXT1 PLXND1 ADGRV1 VIT PLEKHG1 STRN PI4KA PKHD1 KIF5B PLEC TACC3 TRIM36 CLUH NCOA2 STRN3 ARFGEF2 NPRL2 EGFR NT5DC2 ROBO2 CTBP2 | 1.77e-06 | 1113 | 212 | 24 | EFO_0004840 |
| Disease | glycoprotein measurement | 2.46e-06 | 119 | 212 | 8 | EFO_0004555 | |
| Disease | LDL cholesterol change measurement | 1.25e-05 | 7 | 212 | 3 | EFO_0007804 | |
| Disease | progranulin measurement | 1.71e-05 | 22 | 212 | 4 | EFO_0004625 | |
| Disease | fibrinogen measurement, factor VII measurement | 6.14e-05 | 58 | 212 | 5 | EFO_0004619, EFO_0004623 | |
| Disease | granulins measurement | 7.67e-05 | 12 | 212 | 3 | EFO_0008141 | |
| Disease | Diabetes Mellitus | 7.95e-05 | 32 | 212 | 4 | C0011849 | |
| Disease | serum albumin measurement | AOC1 TNFSF13 VSIG4 ADGRV1 PTPRJ CIITA UBP1 MAD1L1 PLEC RAB5C MAP4K3 PKD1L3 LEPR MAP4K5 | 1.07e-04 | 592 | 212 | 14 | EFO_0004535 |
| Disease | alkaline phosphatase measurement | ACAP1 AOC1 PGAP3 SLC26A4 EVC PTPRJ UBP1 NLGN2 CLUH NCOA2 APOB ST3GAL4 ACVR1C PKD1L3 LEPR CELA3A FAM216B MAP4K5 LSM14B | 1.45e-04 | 1015 | 212 | 19 | EFO_0004533 |
| Disease | Ciliopathies | 1.47e-04 | 110 | 212 | 6 | C4277690 | |
| Disease | lymphocyte count | MYO1G ACAP1 AOC1 SLC26A4 EML6 CDH23 PLXND1 PTPN4 PTPRJ PLEC DAGLB SEL1L NCOA2 ZAN E2F2 ST3GAL4 LEPR RAB36 NPRL2 EGFR MAP4K5 ROBO2 NEURL4 PCDHGA8 | 1.49e-04 | 1464 | 212 | 24 | EFO_0004587 |
| Disease | Malignant neoplasm of prostate | SLC26A4 NAGLU GCNT1 PTPRK CLU MAD1L1 FGFR4 REC8 NCOA2 ANXA3 IVNS1ABP EGFR ROBO2 CTBP2 | 1.61e-04 | 616 | 212 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | SLC26A4 NAGLU GCNT1 PTPRK CLU MAD1L1 FGFR4 REC8 NCOA2 ANXA3 IVNS1ABP EGFR ROBO2 CTBP2 | 1.61e-04 | 616 | 212 | 14 | C0033578 |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 1.79e-04 | 114 | 212 | 6 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 1.79e-04 | 114 | 212 | 6 | EFO_0004574, EFO_0004611 | |
| Disease | ciliopathy (implicated_via_orthology) | 1.93e-04 | 40 | 212 | 4 | DOID:0060340 (implicated_via_orthology) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.16e-04 | 118 | 212 | 6 | EFO_0001645, EFO_0004629 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.06e-04 | 45 | 212 | 4 | EFO_0004623, EFO_0004791 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 3.08e-04 | 126 | 212 | 6 | EFO_0004611, EFO_0010351 | |
| Disease | testosterone measurement | KIF18A AOC1 STAG1 MYO5A TNFSF13 SPNS2 ADCY6 GALNT13 PTPN9 PTPRJ TGFBRAP1 NLGN2 USH2A MGRN1 DAGLB ZAN LEPR ZC3H7A ORM1 MAP4K5 LRP5 | 3.69e-04 | 1275 | 212 | 21 | EFO_0004908 |
| Disease | phospholipids in medium LDL measurement | 4.26e-04 | 49 | 212 | 4 | EFO_0022183 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 4.26e-04 | 49 | 212 | 4 | EFO_0022256 | |
| Disease | apolipoprotein A 1 measurement | AOC1 STAG1 FGFR4 HERC1 DAGLB NCOA2 ITGA10 APOB ST3GAL4 PKD1L3 LEPR CELSR2 GUCA2B MAP4K5 CES3 CTBP2 | 4.49e-04 | 848 | 212 | 16 | EFO_0004614 |
| Disease | leptin receptor measurement | 5.07e-04 | 5 | 212 | 2 | EFO_0004635 | |
| Disease | insulin-like growth factor-binding protein 1 measurement | 5.07e-04 | 5 | 212 | 2 | EFO_0020474 | |
| Disease | total lipids in LDL measurement | 5.35e-04 | 52 | 212 | 4 | EFO_0022308 | |
| Disease | white matter microstructure measurement | PLEKHG1 STRN PLEC SLC27A3 STRN3 APOB EGFR ROBO2 SLC35F2 CPNE7 | 5.58e-04 | 390 | 212 | 10 | EFO_0005674 |
| Disease | phospholipids in large LDL measurement | 5.76e-04 | 53 | 212 | 4 | EFO_0022174 | |
| Disease | Colorectal Carcinoma | CPAMD8 ACAP1 TNFSF13 ABCA12 FBLN2 NLGN4X SH3TC1 PKHD1 RAB5C AGTPBP1 ABCB6 APOB EGFR ABCE1 | 5.97e-04 | 702 | 212 | 14 | C0009402 |
| Disease | triglycerides in medium HDL measurement | 6.18e-04 | 54 | 212 | 4 | EFO_0022321 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 6.27e-04 | 144 | 212 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 7.10e-04 | 56 | 212 | 4 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | corpus collosum mid-posterior volume measurement | 7.48e-04 | 25 | 212 | 3 | EFO_0010300 | |
| Disease | Liver Failure | 7.56e-04 | 6 | 212 | 2 | C0085605 | |
| Disease | neural cell adhesion molecule 1, 120 kda isoform measurement | 7.56e-04 | 6 | 212 | 2 | EFO_0020593 | |
| Disease | serine protease inhibitor Kazal-type 2 measurement | 7.56e-04 | 6 | 212 | 2 | EFO_0802054 | |
| Disease | total lipids in large LDL | 7.59e-04 | 57 | 212 | 4 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 7.59e-04 | 57 | 212 | 4 | EFO_0021901 | |
| Disease | phospholipids in LDL measurement | 8.11e-04 | 58 | 212 | 4 | EFO_0022294 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.32e-04 | 152 | 212 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | adverse effect, response to xenobiotic stimulus | 8.65e-04 | 59 | 212 | 4 | EFO_0009658, GO_0009410 | |
| Disease | phospholipids in small LDL measurement | 8.65e-04 | 59 | 212 | 4 | EFO_0022297 | |
| Disease | neutrophil count, eosinophil count | 9.19e-04 | 213 | 212 | 7 | EFO_0004833, EFO_0004842 | |
| Disease | Colorectal Neoplasms | 9.30e-04 | 277 | 212 | 8 | C0009404 | |
| Disease | neutrophil count | MYO1G CPAMD8 ACAP1 NUP210L EML6 CDH23 MAP3K5 EHD4 PTPRJ TGFBRAP1 FGFR4 DAGLB E2F2 LCT LEPR ZC3H7A CELA3A VANGL1 MAP4K5 NBPF10 ATP6V0A2 | 1.04e-03 | 1382 | 212 | 21 | EFO_0004833 |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 1.05e-03 | 7 | 212 | 2 | EFO_0801657 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.11e-03 | 63 | 212 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | remnant cholesterol measurement | 1.12e-03 | 108 | 212 | 5 | EFO_0010815 | |
| Disease | fibrinogen measurement | 1.16e-03 | 109 | 212 | 5 | EFO_0004623 | |
| Disease | mean platelet volume | AOC1 MYO5A NUP210L EML6 PLXND1 ITGA2B STRN PTPRJ PI4KA PLEC DAGLB STRN3 ZAN ST3GAL4 LEPR MAP4K5 PCDHGA8 | 1.18e-03 | 1020 | 212 | 17 | EFO_0004584 |
| Disease | neutrophil count, basophil count | 1.23e-03 | 224 | 212 | 7 | EFO_0004833, EFO_0005090 | |
| Disease | coronary artery disease, factor VII measurement | 1.26e-03 | 111 | 212 | 5 | EFO_0001645, EFO_0004619 | |
| Disease | myeloid white cell count | MYO1G ACAP1 EML6 CDH23 CTIF MAP3K5 EHD4 PTPRJ TGFBRAP1 ITGA10 E2F2 LCT LEPR CELA3A MAP4K5 CES3 | 1.29e-03 | 937 | 212 | 16 | EFO_0007988 |
| Disease | D dimer measurement | 1.29e-03 | 30 | 212 | 3 | EFO_0004507 | |
| Disease | free cholesterol measurement | 1.37e-03 | 113 | 212 | 5 | EFO_0008591 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.40e-03 | 8 | 212 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.42e-03 | 31 | 212 | 3 | EFO_0022249 | |
| Disease | total cholesterol measurement, C-reactive protein measurement | 1.42e-03 | 31 | 212 | 3 | EFO_0004458, EFO_0004574 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.55e-03 | 69 | 212 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | microcephaly (implicated_via_orthology) | 1.56e-03 | 32 | 212 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 1.56e-03 | 32 | 212 | 3 | C0149782 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.73e-03 | 71 | 212 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 1.78e-03 | 120 | 212 | 5 | EFO_0004611, EFO_0004639 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.79e-03 | 9 | 212 | 2 | C0085548 | |
| Disease | IGA Glomerulonephritis | 1.86e-03 | 34 | 212 | 3 | C0017661 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 2.02e-03 | 35 | 212 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | triacylglycerol 52:4 measurement | 2.19e-03 | 36 | 212 | 3 | EFO_0010416 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 2.23e-03 | 10 | 212 | 2 | OBA_2045163 | |
| Disease | creatinine measurement | INTU STAG1 EVC ADGRV1 SQOR PTPN9 PTPRJ PKHD1 FGFR4 PLEC KBTBD2 PKD1L3 CELSR2 MAP4K5 LSM14B CPNE7 | 2.35e-03 | 995 | 212 | 16 | EFO_0004518 |
| Disease | esterified cholesterol measurement | 2.36e-03 | 128 | 212 | 5 | EFO_0008589 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 2.37e-03 | 37 | 212 | 3 | EFO_0022281 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.44e-03 | 78 | 212 | 4 | EFO_0022187 | |
| Disease | granulocyte count | 2.51e-03 | 254 | 212 | 7 | EFO_0007987 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.52e-03 | 189 | 212 | 6 | EFO_0009932 | |
| Disease | smoking cessation | 2.54e-03 | 325 | 212 | 8 | EFO_0004319 | |
| Disease | serum gamma-glutamyl transferase measurement | STAG1 NUP210L NAGLU STRN PKHD1 IFT80 NR1I3 CAMK2G ANXA3 E2F2 ST3GAL4 CELSR2 MAP4K5 LSM14B EPHB1 | 2.64e-03 | 914 | 212 | 15 | EFO_0004532 |
| Disease | coagulation factor XA measurement | 2.71e-03 | 11 | 212 | 2 | EFO_0020266 | |
| Disease | thrombin generation potential measurement | 2.71e-03 | 11 | 212 | 2 | EFO_0005538 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 2.71e-03 | 11 | 212 | 2 | OBA_2045170 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 2.76e-03 | 39 | 212 | 3 | EFO_0022332 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.97e-03 | 40 | 212 | 3 | EFO_0004746 | |
| Disease | free cholesterol in medium LDL measurement | 2.97e-03 | 40 | 212 | 3 | EFO_0022268 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 3.17e-03 | 137 | 212 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 3.23e-03 | 12 | 212 | 2 | EFO_0801493 | |
| Disease | non-alcoholic steatohepatitis | 3.23e-03 | 12 | 212 | 2 | EFO_1001249 | |
| Disease | decanoylcarnitine measurement | 3.23e-03 | 12 | 212 | 2 | EFO_0021039 | |
| Disease | monocyte count | RNGTT STAG1 NAGLU CDH23 ADGRV1 GCNT1 MAP3K5 EHD4 CIITA PI4KA RAB5C DAGLB ST3GAL4 LCT LEPR EGFR MAP4K5 CES3 MYBPC1 | 3.26e-03 | 1320 | 212 | 19 | EFO_0005091 |
| Disease | lipoprotein measurement, phospholipid measurement | 3.33e-03 | 85 | 212 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | Autism Spectrum Disorders | 3.33e-03 | 85 | 212 | 4 | C1510586 | |
| Disease | volumetric bone mineral density | 3.42e-03 | 42 | 212 | 3 | EFO_0007620 | |
| Disease | smoking behavior, BMI-adjusted waist-hip ratio | 3.47e-03 | 86 | 212 | 4 | EFO_0004318, EFO_0007788 | |
| Disease | complex trait | 3.58e-03 | 271 | 212 | 7 | EFO_0010578 | |
| Disease | intermediate density lipoprotein measurement | 3.62e-03 | 87 | 212 | 4 | EFO_0008595 | |
| Disease | liver fat measurement | 3.65e-03 | 43 | 212 | 3 | EFO_0010821 | |
| Disease | triglycerides in large LDL measurement | 3.65e-03 | 43 | 212 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 3.65e-03 | 43 | 212 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.65e-03 | 43 | 212 | 3 | EFO_0022290 | |
| Disease | reticulocyte count | MYO1G EML6 CTIF CNOT8 EHD4 STRN PTPRJ HERC1 SEC14L4 ABCB6 E2F2 ST3GAL4 ACVR1C MAP4K5 NT5DC2 LRP5 | 3.79e-03 | 1045 | 212 | 16 | EFO_0007986 |
| Disease | coagulation factor X measurement | 3.80e-03 | 13 | 212 | 2 | EFO_0020265 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.80e-03 | 13 | 212 | 2 | C1846647 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRDRNYQGIVQYAVS | 211 | Q8TAA9 | |
| YQGIVQYAVSLVDAL | 216 | Q8TAA9 | |
| AVISELDAIQVNYYL | 221 | Q8TD30 | |
| YEGENTVLYLQVARF | 436 | Q99424 | |
| YSLIQRIEAEQNALY | 876 | Q96N23 | |
| VYTLGVADYNLDQIT | 206 | A6NF34 | |
| LAVITREDNLYYGNL | 306 | Q86XM0 | |
| LGVQRVYTLQDLLYQ | 221 | P56545 | |
| RFIDSYVLEYQVQGL | 26 | O43310 | |
| GNIRLAYVYLDSEVT | 206 | Q96QU6 | |
| LVYCLLSQQVREQYG | 776 | Q9UHX3 | |
| TVSDVRILQSYYDQG | 641 | Q96BT7 | |
| DNIEYITIIAFAQYV | 41 | P43652 | |
| ITRATLQYLNGDYEV | 516 | O43306 | |
| TREAYANIAELDQYV | 91 | P33076 | |
| NRLNYYVGGEIVTIA | 541 | P35606 | |
| SQVIYNLTGQRVENY | 1871 | Q86UK0 | |
| QLLGYITQREALSYA | 71 | Q8N7L0 | |
| VENAVGSIRYNYLLD | 226 | P22455 | |
| YLNVQRENGTVSRYE | 96 | P19652 | |
| GSLYDYLNRNIVTVA | 276 | Q8NER5 | |
| VYQYGVATVIIEAND | 1101 | Q8WXG9 | |
| VYAQNLEAQVGLDYI | 2996 | Q8WXG9 | |
| ALYVQESVAVLYIVR | 3091 | Q8WXG9 | |
| EGTILQTVRTCYNIY | 156 | Q9Y6D5 | |
| AQRQLIVKEYQAAYG | 51 | P12429 | |
| QVGDYVLFGTYIIQL | 526 | Q9NP58 | |
| YRGRALDYALQINVI | 166 | Q15027 | |
| RENVAQYVLRAYAVD | 881 | Q9HCU4 | |
| IYQIYEGTSQIQRLI | 396 | P11310 | |
| IAYEVSVQEAVALYG | 346 | P19801 | |
| AYKAVNALQSVYGVR | 351 | Q8N4T0 | |
| VDRGYVQVLLTIYVD | 241 | Q9UPW5 | |
| DQDIYAVVTYQLLGA | 1991 | Q9H251 | |
| YQFSGVYVAIQAVLT | 131 | P61160 | |
| VYVAIQAVLTLYAQG | 136 | P61160 | |
| TQNYLNVYAAEGLRT | 796 | O60312 | |
| QAVQELVSLYYEEAR | 566 | P54802 | |
| YVDTILNLIRIAGDY | 441 | O94973 | |
| AQGVLLVYDITNYQS | 86 | P51157 | |
| GVIRVYSQQCQYLVE | 76 | O95072 | |
| IVAVRTTGNVYAYEA | 116 | Q13356 | |
| AYYRGAQVIITAFDL | 191 | O95755 | |
| YRGAQAAIVVYDITN | 91 | P51148 | |
| TGVLYALQSFDYEQI | 511 | Q9Y5G5 | |
| NYLNTARTLELYGVE | 206 | P29074 | |
| LVDYVNARQKQGIYE | 291 | P43378 | |
| GIIPRIVQDIFNYIY | 106 | P33176 | |
| YQTLGEEYVSIIQVD | 66 | O60683 | |
| NLVIQYAAQGRYEVA | 216 | Q9NSK0 | |
| AELRSINEAYGYQIQ | 321 | Q14994 | |
| VYVVQVRARTVAGYG | 501 | P54762 | |
| IVPRYIANEIDGVVY | 426 | Q8N6Y1 | |
| LQIAYVSRETLQGLY | 111 | Q8IVH8 | |
| NENTVDVYGIVYDLR | 1261 | Q12913 | |
| LTGYQIDITTENQYR | 636 | Q9Y6D9 | |
| VNGQAVPRYLIYDII | 351 | O60942 | |
| EAVEVLLNYAYTAQL | 81 | Q9Y6Y0 | |
| SEYDQIRYISQTQGL | 396 | Q86Z02 | |
| VIARYRYQQVVVGNV | 371 | Q9UN88 | |
| AVSYLEVYNEQIRDL | 156 | Q8NI77 | |
| QIRYEGILYTIDTDN | 21 | Q9BX40 | |
| QIVDRVSYLLQEIYG | 241 | O60291 | |
| SEIRAVQLSYLYLGA | 2501 | Q15751 | |
| AIVVNAERGYLYFTN | 1071 | O75197 | |
| FVYVDQRATAILGYL | 381 | Q8WYA1 | |
| LADYNNVIYAERVLA | 956 | Q86SJ6 | |
| ERIYQVVDSVYSNIL | 6416 | Q5CZC0 | |
| VVAGTSQLYVYRLNR | 31 | Q10570 | |
| NVVLVGSLQDRYVPY | 1416 | Q9P2D6 | |
| NAYTGVVYLQRAVLE | 1136 | P98095 | |
| VYLAAVNRLYQLSGA | 71 | Q9Y4D7 | |
| QGVITVIDVFYQYAT | 6 | Q86YZ3 | |
| NVDAATLQIIITYAY | 76 | Q8IY47 | |
| GCLVITGNQYIYQEV | 661 | P42356 | |
| NEAGLNYYVRLIDTL | 1466 | P09848 | |
| VQVRARTVAGYGQYS | 521 | P54753 | |
| RYAELYVIDVNINIS | 421 | P48357 | |
| NGRYISLILAVQIAY | 6 | Q9NPD7 | |
| IYIQLQREYQISAGD | 341 | Q9H223 | |
| YGEEYAVQLTLQVLR | 61 | O15553 | |
| IFEVYRVEIQNLTYA | 176 | Q9Y616 | |
| SFELIVVQNYLYAVN | 476 | Q8WVZ9 | |
| VLASYGNVIVITVNY | 236 | Q8N2Q7 | |
| SEVYRLNLEQGRYLN | 156 | Q9BSC4 | |
| YLISQRVTYEQGVRA | 471 | Q9UNW9 | |
| QRYSQTGNYELAVAL | 281 | P39656 | |
| RYNALYSLDGLAVVN | 226 | Q8IYI6 | |
| DTIGEYIALYQSQRA | 841 | Q08379 | |
| GALEYDQIRYISQTQ | 401 | Q9H422 | |
| VCAQYRQVRFYEGVV | 916 | O75694 | |
| QYITDIAAEQLSYVI | 561 | Q9UMZ3 | |
| RYYSLGEIRNVETNQ | 426 | Q8IUC8 | |
| GVIVQQRYKDVNVYV | 151 | Q9ULD6 | |
| EQIQGEALSYYLARL | 186 | Q86VR8 | |
| SYGNVIVITLNYRVG | 226 | Q9NZ94 | |
| ASYGNVIVITINYRL | 191 | Q8NFZ3 | |
| VLGNLEITYVQRNYD | 61 | P00533 | |
| QEILTYFRGSELQNY | 141 | P61221 | |
| ELQRYLSLVGQVYST | 2531 | P04114 | |
| AYAAIGEIDKVQYIN | 636 | Q9P2H3 | |
| DILEGLVNYAYTSQI | 86 | Q8NBE8 | |
| GQSIDYRSQVLQTYV | 551 | Q6ZP82 | |
| RLAYVTYQDIRAVGN | 246 | Q14209 | |
| VLGRTLQQLYEAYAS | 86 | Q8WZ79 | |
| YQNILAAIEGSRFYT | 131 | Q16394 | |
| RIYSYAGDNIVTAQA | 31 | O95832 | |
| VYNNGLRTEQDLYVR | 116 | Q9BQW3 | |
| AARYVYQRLINDGIL | 411 | Q8NCG7 | |
| SRDLTYQVVLGEYNL | 76 | P09093 | |
| NFTLYYEVAARGNIV | 481 | Q8IZJ3 | |
| LYRVNDDQGLQLVYR | 256 | Q9UBL6 | |
| SVYIQYQGFRVQLES | 26 | Q16661 | |
| SARQYVYGVLFSLAE | 656 | Q9NX05 | |
| ITAAYIVGYQFIQTD | 26 | Q92819 | |
| VGYQYVITGRNRSLE | 186 | P98153 | |
| NKETGRVYVYLVGQQ | 516 | O75578 | |
| RVYVYLVGQQSLLTL | 521 | O75578 | |
| YLNVQRENGTISRYV | 96 | P02763 | |
| IGEFRSSIDYQYQLL | 51 | Q9UFF9 | |
| VVYFVAGVGVVYNTR | 36 | Q6ZMW3 | |
| VSRLVQAYYQQIGRI | 786 | P57679 | |
| YSNGVRTEQDLYVRL | 116 | Q9H4W6 | |
| QLVVSVGQIYGDVLY | 151 | Q15125 | |
| VSREYVGYVLQNEKI | 291 | Q02742 | |
| AAYGDVVVVTVQYRL | 166 | Q6UWW8 | |
| QRVVSYQIRYEGNVT | 326 | Q8IY37 | |
| LQAGVYVLRFDNTYS | 356 | Q9UDX3 | |
| LAAYGNVIVATLNYR | 201 | Q8NFZ4 | |
| ASYGNVIVITINYRL | 191 | Q8N0W4 | |
| SQVVVAVGRALYYLQ | 506 | Q16531 | |
| AACIAYIRLTQYIDG | 506 | Q13555 | |
| RQLVLIDYGDQYTAR | 71 | Q9Y5B8 | |
| VYAVVDLYGQCVQVS | 866 | Q96JN8 | |
| QEGYRTLIDQQVVYI | 1121 | Q14562 | |
| LDGYARLVQQTILCY | 11 | P46019 | |
| QIAYVCRETLQGLAY | 116 | Q9Y4K4 | |
| QYIYRIQCLDLGEQV | 716 | Q5VU65 | |
| IGSTGLVVYDYQQLL | 96 | P11686 | |
| RSGYIAIDDIQVLSY | 176 | Q15262 | |
| LIRFDYGYNLVANVA | 216 | Q96FM1 | |
| YGIVYAGRDLSNQVR | 691 | Q99683 | |
| YNYQTLRIGGLVFDV | 31 | P58550 | |
| AYYEAAVRAGRLQLN | 176 | Q8IZ73 | |
| ISVDLENGQYQVFYI | 371 | O75445 | |
| RQLLRQYLQEVGYTD | 176 | Q13033 | |
| QYLQEVGYTDTILDV | 181 | Q13033 | |
| LVTGYNRVILAEFDY | 381 | Q9Y6N5 | |
| LLRQYLQEVGYTDTI | 161 | O43815 | |
| LLAAERIQVGYYTSL | 546 | Q9NQ86 | |
| EDYLARITQEGQRYQ | 751 | Q9Y6A5 | |
| AGSIYLIYFVVDRSQ | 331 | Q7Z5M5 | |
| TRVGRLYAVYDQAVS | 341 | O43541 | |
| IQYLLLAEQGYEVAQ | 576 | Q9UBV2 | |
| AVALGISAVAVYDYQ | 426 | P14317 | |
| SAFYVLEQQRVGLAV | 3586 | Q6P3W6 | |
| SAFYVLEQQRVGLAV | 531 | P0DPF2 | |
| SAFYVLEQQRVGLAV | 1751 | P0DPF2 | |
| SAFYVLEQQRVGLAV | 2971 | P0DPF2 | |
| SAFYVLEQQRVGLAV | 4191 | P0DPF2 | |
| YYIRELVDIFVVGQQ | 771 | P21675 | |
| QDTLSNAVIYYRVGD | 341 | Q9NVX7 | |
| ITALVFYINTYAGVN | 106 | P32249 | |
| QTIYEIIDNSQGFYV | 276 | Q9Y617 | |
| VLRNRGVYENVKYVQ | 441 | Q96CC6 | |
| YYITAVLSERQEGAQ | 606 | Q7Z443 | |
| YFYVAGSVILNIRLQ | 51 | P0DMW3 | |
| RQYGDGYLLQVQELV | 21 | Q9NYZ4 | |
| YDVVIRLNNAPVAGY | 141 | Q11206 | |
| LYIQVAQNVALYTGD | 1091 | Q8TE82 | |
| YIIYLVEGQSVINSQ | 391 | Q96GZ6 | |
| GNVLNYLDRYTVAGV | 111 | Q8IVW8 | |
| YLDRYTVAGVLLDIQ | 116 | Q8IVW8 | |
| YIGALLAIRRQYQSI | 1166 | Q8IZU2 | |
| TQDGYVSFYNLAVLI | 3806 | P08F94 | |
| TYRVTQYANLLAAQG | 741 | Q9NQW1 | |
| LIVGAYGANQVAVYR | 466 | P08514 | |
| GVVTLVSILQYSNVY | 231 | Q8WTW4 | |
| LADVEANYVIVRAYQ | 116 | Q8IXU6 | |
| ISVDGVVYYRVQNAT | 116 | P27105 | |
| VVYYRVQNATLAVAN | 121 | P27105 | |
| TYDYGRQLLQATVVL | 551 | Q86VW0 | |
| TQGEDQYYLRVTTVA | 376 | P10909 | |
| VRTYNAVDVEGLYTL | 456 | O75153 | |
| VVFVSENVTQYLRYN | 136 | Q15596 | |
| VRYIDYGNTEILNRS | 111 | Q9BXU1 | |
| QYNIRGVTYRLTQGV | 291 | Q8TBC4 | |
| VALGLARSENLIYTY | 786 | Q8WUH2 | |
| LAQLLEGYARYSVSV | 856 | O94966 | |
| AVYRIRGSVSAANYI | 41 | Q96KV7 | |
| AGRERAVYTSVQAQY | 206 | Q6ZSR9 | |
| LQYRSVGTSQELLEY | 561 | Q5GH72 | |
| RDYVYSIINGIVFNL | 71 | Q9NYG2 | |
| YVLRAAQLALVYVSQ | 66 | Q96CM4 | |
| NYNGVLSIIYTLVEI | 246 | O43511 | |
| IDVNVYFASLQDYVI | 686 | O43511 | |
| YVGDSALQLERINVY | 36 | Q9BUF5 | |
| VFQYIGELCRYLVNQ | 371 | Q5K4L6 | |
| SYQQGVLSATILYEI | 136 | P01850 | |
| RSQAYADYIGFILTL | 41 | Q15257 | |
| VADLYELVQYAGNII | 91 | Q96QK1 | |
| VAAEGAYYLEQVTIT | 36 | Q8N0X2 | |
| ELQYRNYGTQLETDI | 391 | Q6P2S7 | |
| DTRIGAVQYTYEQRL | 531 | Q6UXI7 | |
| FIGVLIRQCQYSIIY | 181 | Q8WVM7 | |
| LTITNIQRSDAGYYI | 376 | Q9HCK4 | |
| QEYRLSAFVDVGLYQ | 466 | Q86WI1 | |
| YREVVLNATYISLQG | 3096 | Q86WI1 | |
| EYQIIAQINGNYARL | 366 | Q9Y279 | |
| IYANNEISLRDVEVY | 56 | Q9H857 | |
| TEIIRQQGLASYDYV | 3766 | Q15149 | |
| VRYYSELENAQSILQ | 511 | Q8NDW8 | |
| EDYSNYISRVVAVIG | 126 | Q8TE23 | |
| ALRVRVNTYYIVGLQ | 51 | O60844 | |
| ETLTYLNQGQSYEIR | 81 | Q9NZI7 | |
| TQEQYAVYLRALVRN | 31 | Q8IWR0 | |
| QLLRQYLEEVGYTDT | 176 | Q9NRL3 | |
| SYQQGVLSATILYEI | 136 | A0A5B9 | |
| QDTYNVAIRNYGRLL | 1016 | Q6PGP7 | |
| IGARIAEYSQLYDQI | 1031 | Q9ULL1 | |
| QLYRAEDGRVYNLTA | 86 | Q502W6 | |
| SLNSQLVYEYVVERF | 686 | Q5TAX3 | |
| SVNRYILQLAQEYCG | 3791 | Q5T4S7 | |
| RIQDAGVYLLYSQVL | 156 | O75888 | |
| GVYLLYSQVLFQDVT | 161 | O75888 | |
| DAGVAVLRAYNYVAQ | 546 | Q9NYU2 | |
| DGINVTIRRNYIYED | 721 | Q15386 | |
| LYTGQEYVQRVLLVV | 641 | Q9Y487 | |
| VYIDIYDAQVTLQKG | 1991 | Q9Y493 | |
| GRIYTYIGEVLVSVN | 36 | B0I1T2 | |
| AEYRQVLSDLAIQIY | 1596 | Q9Y4I1 | |
| TITELVIGNEYYFRV | 991 | Q00872 |